Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling multiscale neural dynamics for EEG-based emotion recognition using an attentive wavelet-transformer framework.

Frontiers in computational neuroscience·2026
Same author

EEG-based dynamic emotion recognition using multi-scale wavelet transform with a Spatio-Temporal neural network.

Scientific reports·2026
Same author

Ensemble fuzzy multilayer neural perceptron with optimized feature selection for cardiac disease prediction using MRI and ECG data.

Frontiers in physiology·2026
Same author

Fabrication of strontium-doped Bi<sub>2</sub>S<sub>3</sub> Thin films based high performance photodetectors for optoelectronic devices.

Scientific reports·2025
Same author

Effect of Flux and Co-doping on Photoluminescence Properties of Zn<sub>2</sub>SiO<sub>4</sub>:Eu<sup>3+</sup> Red Phosphors for Blue LED Excitable White LED Applications.

Journal of fluorescence·2024
Same author

Evidence of microRNAs origination from chloroplast genome and their role in regulating Photosystem II protein N (psbN) mRNA.

Biotechnologia·2024

Related Experiment Video

Updated: Jun 28, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

A Computer Aided Diagnosis System for Identifying Alzheimer's from MRI Scan using Improved Adaboost.

S Saravanakumar1, P Thangaraj2

  • 1Research Scholar, Anna University, Chennai, Tamilnadu, India. sar112113118@gmail.com.

Journal of Medical Systems
|February 14, 2019
PubMed
Summary
This summary is machine-generated.

This article presents a computer-aided system designed to identify Alzheimer's disease using brain MRI scans. By combining advanced machine learning techniques, the researchers developed a method to improve the accuracy of detecting brain volume abnormalities associated with cognitive decline.

Keywords:
Alzheimer’s Disease (AD)Genetic Algorithms (GA) and Greedy SearchMagnetic Resonance Imaging (MRI)Principal Component Analysis (PCA)Voxel-Based Morphometry (VBM)machine learningvoxel-based morphometrygenetic algorithmgrey matter volumediagnostic accuracy

Frequently Asked Questions

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 28, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

Area of Science:

  • Neuroimaging diagnostics within Alzheimer's Disease research
  • Computational intelligence and Adaboost pattern recognition

Background:

No prior work had fully resolved the optimal integration of ensemble learning for automated neuroimaging classification. Prior research has shown that morphometric analysis of brain volume provides insights into neurodegenerative conditions. That uncertainty drove the development of automated systems for evaluating grey matter changes. It was already known that voxel-based morphometry serves as a standard for comparing patient scans against healthy controls. This gap motivated the exploration of more robust algorithmic frameworks for diagnostic precision. Researchers have previously utilized various classifiers to distinguish between healthy subjects and those with cognitive impairment. However, existing models often struggle with high-dimensional data and classification error bounds. That limitation necessitated the investigation of improved boosting strategies for clinical applications.

Purpose Of The Study:

The primary aim of this work was to develop a computer-aided system for identifying Alzheimer's disease using MRI scans. Researchers sought to address the limitations of existing classification models in handling complex neuroimaging data. This project focused on improving the accuracy of detecting brain volume abnormalities associated with cognitive decline. The team investigated whether specific algorithmic enhancements could reduce classification error bounds. By utilizing voxel-based morphometry, the authors intended to automate the comparison of patient scans with healthy controls. The study was motivated by the need for more reliable tools to assist in the early detection of neurodegenerative conditions. The researchers specifically targeted the optimization of weak classifier permutations to build stronger diagnostic models. This effort aimed to provide a more efficient and precise alternative to traditional machine learning techniques in clinical settings.

Main Methods:

The review approach focuses on integrating machine learning algorithms to process structural brain scans. Researchers employed voxel-based morphometry to quantify grey matter volumes across different patient cohorts. A principal component analysis was utilized to reduce data dimensionality and enhance overall system efficiency. The study design incorporates a genetic algorithm to optimize the selection of weak classifiers. This methodology allows for the independent calculation of fitness scores during the training phase. A greedy search strategy was implemented to explore various permutations of the ensemble components. The team compared these optimized configurations against traditional boosting methods to assess performance gains. High-performance computing resources supported the execution of these complex algorithmic operations throughout the experiment.

Main Results:

Key findings from the literature indicate that the proposed system successfully reduces classification error bounds compared to classical methods. The experiment demonstrates that genetic algorithms effectively boost the performance of weak classifier permutations. These results suggest that the optimized ensemble approach yields more accurate diagnostic solutions for identifying Alzheimer's disease. The researchers observed that the integration of greedy search strategies enhances the reliability of the classification process. Data analysis confirmed that the system maintains efficiency while processing high-dimensional morphometric information. The findings highlight that the proposed technique outperforms standard boosting in identifying patterns related to cognitive impairment. Experimental evidence shows that the combination of these computational tools provides a robust framework for neuroimaging analysis. The study confirms that the refined classifier selection process leads to improved diagnostic outcomes in the tested scenarios.

Conclusions:

The authors propose that genetic algorithms offer a viable alternative for enhancing ensemble learning performance. Their findings suggest that optimizing the selection of weak classifiers leads to superior diagnostic outcomes. This synthesis implies that combining greedy search strategies with boosting improves classification accuracy. The study demonstrates that these computational permutations outperform classical approaches in specific experimental settings. Researchers conclude that the proposed system effectively reduces the upper bound of classification errors. The evidence supports the integration of evolutionary computation into standard diagnostic pipelines. These results indicate that automated systems can reliably identify patterns associated with cognitive decline. The authors emphasize that their approach provides a more efficient framework for processing complex neuroimaging datasets.

The researchers propose that a genetic algorithm optimizes the selection of weak classifiers within the boosting framework. This mechanism reduces the upper bound of classification errors, providing better solutions than the classical version of the algorithm.

Principal Component Analysis serves as the primary tool for dimensionality reduction. This technique improves computational efficiency by simplifying the high-dimensional data extracted from MRI scans before the classification process begins.

The authors utilize a greedy search strategy because it allows for an independent calculation of fitness scores. This approach is necessary to facilitate easier computation alongside high-performance computing systems.

The system utilizes MRI scans to evaluate grey matter volumes. This data type is essential for identifying abnormalities that distinguish patients with Alzheimer's disease or mild cognitive impairment from healthy control subjects.

The system measures the classification error bound to evaluate performance. This phenomenon is compared against classical boosting techniques to demonstrate the efficacy of the new genetic algorithm-based approach.

The researchers propose that their improved boosting technique provides a superior alternative for identifying patterns in neuroimaging. This implication suggests that future diagnostic tools could benefit from evolutionary optimization to increase accuracy.